Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.Mechanisms of phthalate ester toxicity in the female reproductive systemDecreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case seriesEndocrine disrupters as obesogensAtrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humansInsulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskUp-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture modelEffect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: in vivo and ex vivo studiesEffects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN.Meta-Analysis of Microarray Data of Rainbow Trout Fry Gonad Differentiation Modulated by Ethynylestradiol.Summary of information on human CYP enzymes: human P450 metabolism data.Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells.Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolismPPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.Aromatase activity and bone loss in men.Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).Rosiglitazone and pioglitazone alter aromatase kinetic properties in human granulosa cellsExpression Levels of PPARγ and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells: Influence of ω-3 Fatty AcidRole of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovaryPPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Targets to treat metabolic syndrome in polycystic ovary syndromeKey developments in endocrine disrupter research and human health.Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol.Activation of PPARγ by Rosiglitazone does not negatively impact male sex steroid hormones in diabetic rats.Sex differences, endogenous sex-hormone hormones, sex-hormone binding globulin, and exogenous disruptors in diabetes and related metabolic outcomes.Troglitazone: a possible modulator of ovarian steroidogenesis.Tributyltin synergizes with 20-hydroxyecdysone to produce endocrine toxicity.Fenofibrate, a ligand for PPARalpha, inhibits aromatase cytochrome P450 expression in the ovary of mouse.Involvement of peroxisome proliferator-activated receptors in the estradiol production of ovine Sertoli cells.Nuclear Receptor Profiling of Ovarian Granulosa Cell Tumors
P2860
Q21245560-44A902EE-E33B-4FD1-B843-BF9AB1861DE4Q24529989-72F5A9CA-F000-4AF8-ABED-CBAE43C4E7EBQ24645442-D5DF6E66-46A7-48AD-A056-3FACAC24A7F9Q24647272-3C26FE0B-C8FC-49D7-9FB9-520F82C1EC19Q24685808-01BD68DC-EDB0-430A-BB44-01198CF643C1Q28072521-6349BCCB-5E7B-4939-895F-005497A0CE1BQ28361807-AA52A708-84B2-4C1E-A337-694CF4EA6A4AQ28363408-AE9F6ACC-378B-4585-9889-3830C1A127D1Q28575457-43AD3A61-7032-4C4F-842A-9FF08BB39777Q30317260-AA80BE19-3474-4697-8761-6B826A461160Q30993997-17EACDDE-6353-4C2C-9739-CC229EDADFE8Q32103802-7FBACB38-AE14-491D-9422-C7681801B96EQ33555875-46852F93-7DA0-4BD5-BD52-58030F76E960Q33579464-B4AF5753-153D-4D85-B6E4-0E2DB6D027D8Q33584946-63708820-9CFC-4D46-A8A2-8B0D27D89C5BQ35101538-3CC46D68-2F88-45FC-A502-7CA6E50B28CBQ35606054-C3096867-FD13-4B98-B8ED-F5AD902B2E15Q35636330-DA257E63-57D3-4AD5-8512-3D3C951A40BCQ35898949-BF16A857-A93E-466F-AD63-B00CCB666E4EQ36426752-2B3DA6EC-3F59-459B-A20B-86BEEF8E8DD9Q36465006-849C6C91-5196-4C6E-B6E3-D8B4D15614D5Q36943683-096316D2-1019-4E74-9560-380FA861447BQ37119910-0A8604A5-104C-4E15-A7CA-5C34172FBB74Q37220908-62A7E4BD-1BAC-473C-AC4E-42CC92EAA69AQ37226962-EE9CBF70-34BD-4F86-ACD8-6727C81233DFQ40418781-6A2D0BDD-687E-4D39-B261-232F839BBF95Q42521319-141E8148-CA27-4BD5-85D3-8EA454995FC5Q42732302-F2053C97-561D-4F45-9CA6-39371EE30956Q44308529-15B93BDE-3BC1-4C91-BB93-EC9BEE28191AQ47166749-399133BD-4BE1-4961-8EB0-4191A5892B60Q58433687-37EFAACC-1FB7-4A08-B44D-DEFD131E9583
P2860
Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells.
@ast
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells.
@en
type
label
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells.
@ast
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells.
@en
prefLabel
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells.
@ast
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells.
@en
P2093
P356
P1476
Insulin sensitizer, troglitazo ...... human ovarian granulosa cells
@en
P2093
R Takayanagi
P304
P356
10.1006/BBRC.2000.2701
P407
P577
2000-05-01T00:00:00Z